Marina Pavanello
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Homologous Recombination Proficiency in High-Grade Serous Epithelial Ovarian Cancer Tumors: The Dark Side of the Moon.
Journal: Current issues in molecular biology
Published: July 17, 2025
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.
Journal: European journal of human genetics : EJHG
Published: October 04, 2024
Exome sequencing identifies HELB as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer.
Journal: medRxiv : the preprint server for health sciences
Published: April 18, 2024
MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: September 13, 2021
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.
Journal: The oncologist
Published: December 27, 2020
Rare Germline Genetic Variants and the Risks of Epithelial Ovarian Cancer.
Journal: Cancers
Published: September 16, 2020
Role of discoidin domain receptor 2 (DDR2) and microRNA-182 in survival of women with high-grade serous ovarian cancer.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: February 28, 2019
Expression of unusual immunohistochemical markers in mucinous breast carcinoma.
Journal: Acta histochemica
Published: February 27, 2017
Dystrophin Is Required for Proper Functioning of Luminance and Red-Green Cone Opponent Mechanisms in the Human Retina.
Journal: Investigative ophthalmology & visual science
Published: July 09, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026